scholarly article | Q13442814 |
P50 | author | Kaare Christensen | Q30119824 |
Kirsten Kyvik | Q37389927 | ||
Laszlo Hegedüs | Q89254124 | ||
P2093 | author name string | Brix TH | |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Graves' disease | Q50357588 |
P304 | page(s) | 930-934 | |
P577 | publication date | 2001-02-01 | |
P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
P1476 | title | Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts | |
P478 | volume | 86 |
Q36938349 | 'Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid disease |
Q57136607 | 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism |
Q91875885 | A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Graves' Hyperthyroidism and Graves' Orbitopathy |
Q37290865 | Alcohol consumption as a risk factor for autoimmune thyroid disease: a prospective study |
Q34391184 | Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease |
Q83891735 | Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease |
Q37475754 | Association between TSHR gene polymorphism and the risk of Graves' disease: a meta-analysis |
Q47129623 | Association between polymorphism within interleukin related genes and Graves' disease: a meta-analysis of 22 case-control studies |
Q33951536 | Association between polymorphisms in the TSHR gene and Graves' orbitopathy. |
Q36416583 | Association between the CTLA-4 +49A/G polymorphism and Graves’ disease: A meta-analysis |
Q33706977 | Association of 4p14 and 6q27 variation with Graves disease: a case-control study and a meta-analysis of available evidence. |
Q35998164 | Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study |
Q35052064 | Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population. |
Q64230385 | Association of single-nucleotide polymorphisms in the IL27 gene with autoimmune thyroid diseases |
Q36077116 | Association of the CTLA4 gene CT60/rs3087243 single-nucleotide polymorphisms with Graves' disease |
Q33547454 | Association of the CTLA4 gene with Graves' disease in the Chinese Han population |
Q81288034 | Association study between the IL4, IL13, IRF1 and UGRP1 genes in chromosomal 5q31 region and Chinese Graves' disease |
Q67209937 | Autoimmune disease in a DFNA6/14/38 family carrying a novel missense mutation in WFS1. |
Q26767040 | Autoimmune diseases - connecting risk alleles with molecular traits of the immune system |
Q34442814 | Autoimmune thyroid diseases in children |
Q37009991 | Autoimmune thyroid disorders |
Q24595022 | Autoimmune thyroid disorders—An update |
Q37193226 | Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. |
Q34086596 | Autoimmunity in patients with resistance to thyroid hormone |
Q39120292 | CD40 Signaling in Graves Disease Is Mediated Through Canonical and Noncanonical Thyroidal Nuclear Factor κB Activation |
Q36638561 | CTLA-4 Polymorphisms and Systemic Lupus Erythematosus: A Comprehensive Meta-Analysis |
Q33834350 | Cancer risk in patients hospitalised for Graves' disease: a population-based cohort study in Sweden |
Q26749365 | Clinical Relevance of Environmental Factors in the Pathogenesis of Autoimmune Thyroid Disease |
Q38119438 | Clinical practice guidelines for the management of hypothyroidism |
Q33188524 | Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families |
Q33872886 | Comparative Efficacy and Toxicity of Different Species of Sargassum in Haizao Yuhu Decoction in PTU-Induced Goiter Rats. |
Q33816981 | Comprehensive genotyping in two homogeneous Graves' disease samples reveals major and novel HLA association alleles |
Q35760538 | Concordance, disease progression, and heritability of coeliac disease in Italian twins |
Q40883929 | Construction of a population-specific HLA imputation reference panel and its application to Graves' disease risk in Japanese |
Q35575421 | Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity |
Q27691806 | Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. |
Q43186822 | Decreased CD4+CD152+ T cell subset and its correlation with the level of antithyroid antibodies in children with chronic autoimmune thyroiditis |
Q89555164 | Decreased immunoglobulin G core fucosylation, a player in antibody-dependent cell-mediated cytotoxicity, is associated with autoimmune thyroid diseases |
Q38152621 | Diagnosis and management of Graves disease: a global overview |
Q35946146 | Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset. |
Q37198009 | Divergent frequencies of IGF-I receptor-expressing blood lymphocytes in monozygotic twin pairs discordant for Graves' disease: evidence for a phenotypic signature ascribable to nongenetic factors |
Q90395979 | Dysregulated Antibody, Natural Killer Cell and Immune Mediator Profiles in Autoimmune Thyroid Diseases |
Q37836257 | Environmental triggers of thyroiditis: Hepatitis C and interferon-α |
Q36361369 | Excess mortality in hyperthyroidism: the influence of preexisting comorbidity and genetic confounding: a danish nationwide register-based cohort study of twins and singletons |
Q38560347 | Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases |
Q36508965 | Fine Mapping of Loci Linked to Autoimmune Thyroid Disease Identifies Novel Susceptibility Genes |
Q89481438 | Fine mapping MHC associations in Graves' disease and its clinical subtypes in Han Chinese |
Q38093041 | GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. |
Q51335439 | Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves' ophthalmopathy |
Q99712101 | Genetic Association Study of IL2RA, IFIH1, and CTLA-4 Polymorphisms With Autoimmune Thyroid Diseases and Type 1 Diabetes |
Q34231329 | Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes |
Q35080975 | Genetic heterogeneity of susceptibility gene in different ethnic populations: refining association study of PTPN22 for Graves' disease in a Chinese Han population |
Q34171280 | Genetic susceptibility to autoimmune thyroid disease: past, present, and future |
Q36288230 | Genetics of autoimmune thyroid disease in the Lebanese population |
Q46065955 | Genetics of thyroid autoimmunity - update and clinical relevance |
Q34238924 | Genetics of thyroid function and disease |
Q55397546 | Genome-Wide Association Studies of Autoimmune Thyroid Diseases, Thyroid Function, and Thyroid Cancer. |
Q34632596 | Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. |
Q34739056 | Graves' disease in monozygotic twins - a case report |
Q33594405 | Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016 |
Q40607323 | HLA-DRB1 the notorious gene in the mosaic of autoimmunity |
Q33716540 | Hepatitis C and interferon induced thyroiditis |
Q46210690 | Heritability of Addison's disease and prevalence of associated autoimmunity in a cohort of 112,100 Swedish twins |
Q56891783 | How much of the predisposition to Hashimoto's thyroiditis can be explained based on previously reported associations? |
Q35542692 | Hyperthyroid vs hypothyroid eye disease: the same severity and activity |
Q36715841 | Hyperthyroidism in Childhood: Causes, when and how to treat |
Q93149325 | IDENTICAL TWIN SISTERS WITH CLOSE ONSET OF GRAVES' DISEASE AND WITH MULTIPLE HLA SUSCEPTIBILITY ALLELES FOR GRAVES' DISEASE |
Q42633531 | Identification of BACH2 as a susceptibility gene for Graves' disease in the Chinese Han population based on a three-stage genome-wide association study |
Q35730981 | Immunogenetic Mechanisms Leading to Thyroid Autoimmunity: Recent Advances in Identifying Susceptibility Genes and Regions |
Q36236762 | Immunogenetics of autoimmune thyroid diseases: A comprehensive review |
Q37403884 | Incidental Identification of a Thyroid Hormone Receptor Beta (THRB) Gene Variant in a Family with Autoimmune Thyroid Disease |
Q81661426 | Influx of recent thymic emigrants into autoimmune thyroid disease glands in humans |
Q42225256 | Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease |
Q36973929 | Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. |
Q35842892 | Juvenile thyrotoxicosis; can we do better? |
Q50157447 | Left ventricular functions in children with newly diagnosed Graves' disease. A single-center study from Upper Egypt |
Q64108589 | Linkage Analysis of the Chromosome 5q31-33 Region Identifies JAKMIP2 as a Risk Factor for Graves' Disease in the Chinese Han Population |
Q26827065 | Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics |
Q64076724 | Molecular Insights Into the Relationship Between Autoimmune Thyroid Diseases and Breast Cancer: A Critical Perspective on Autoimmunity and ER Stress |
Q34789638 | Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study |
Q58709623 | No link between season of birth and subsequent development of Graves' disease or toxic nodular goitre: a nationwide Danish register-based study |
Q36198104 | Pooled genome wide association detects association upstream of FCRL3 with Graves' disease |
Q34328566 | Preliminary evidence of a noncausal association between the X-chromosome inactivation pattern and thyroid autoimmunity: a twin study |
Q47121440 | RNA-Sequencing Gene Expression Profiling of Orbital Adipose-Derived Stem Cell Population Implicate HOX Genes and WNT Signaling Dysregulation in the Pathogenesis of Thyroid-Associated Orbitopathy |
Q37017200 | Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy |
Q92405227 | Regulation of TSHR Expression in the Thyroid and Thymus May Contribute to TSHR Tolerance Failure in Graves' Disease Patients via Two Distinct Mechanisms |
Q38957307 | Relapse prediction in Graves´ disease: Towards mathematical modeling of clinical, immune and genetic markers |
Q35785152 | Relationship between cigarette smoking and Graves' ophthalmopathy |
Q34770032 | Replication of association of nine susceptibility loci with Graves' disease in the Chinese Han population |
Q39672021 | Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis |
Q38271025 | Role of genetic and non-genetic factors in the etiology of Graves' disease. |
Q97419177 | Scintigraphy evaluation of hyperthyroidism and its correlation with clinical and biochemical profiles |
Q89455378 | Selenium in thyroid disorders - essential knowledge for clinicians |
Q37895664 | Serendipitous identification of Graves' disease in identical twins with polydipsia. |
Q53652710 | TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy |
Q33741009 | Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab |
Q79916555 | The A946T polymorphism in the interferon induced helicase gene does not confer susceptibility to Graves' disease in Chinese population |
Q96953538 | The Association Between Foxp3 Polymorphisms and Risk of Graves' Disease: A Systematic Review and Meta-Analysis of Observational Studies |
Q47142211 | The Association of Thyroid Disease and Oral Lichen Planus: A Literature Review and Meta-analysis |
Q24673258 | The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future |
Q36579326 | The etiology of autoimmune thyroid disease: a story of genes and environment |
Q35730994 | The genetic basis of graves' disease |
Q36634117 | The new perspectives on genetic studies of type 2 diabetes and thyroid diseases |
Q28389137 | The role of epigenetic mechanisms and processes in autoimmune disorders |
Q84860756 | The surgical treatment of Graves' disease in children and adolescents |
Q36243615 | The thyroid, the eyes and the gut: a possible connection |
Q35095551 | The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim |
Q30341291 | Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure? |
Q37987063 | Thyroid Eye Disease: Towards an Evidence Base for Treatment in the 21st Century |
Q35919247 | Thyroid associated orbitopathy. |
Q53743982 | Thyroid-associated Ophthalmopathy |
Q28068607 | Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves' Disease |
Q33905841 | Thyrotropin receptor-associated diseases: from adenomata to Graves disease |
Q42668018 | Total Thyroidectomy for Thyroid Cancer Followed by Thyroid Storm due to Thyrotropin Receptor Antibody Stimulation of Metastatic Thyroid Tissue |
Q34706489 | Twins and endocrinology |
Q35696684 | Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond. |
Q34369064 | Women and autoimmune diseases |
Q76384457 | [Endocrine orbit disorders. Pathogenesis, clinical presentation and examination, stage-dependent therapy] |
Q36854711 | beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease. |
Search more.